Effects of docosahexaenoic acid and eicosapentaenoic acid enriched milk beverage consumption on emotion and intestinal microbiota in Minors

Effects of docosahexaenoic acid and eicosapentaenoic acid enriched milk beverage consumption on emotion and intestinal microbiota in Minors - Effects of docosahexaenoic acid and eicosapentaenoic acid enriched milk beverage consumption on emotion and intestinal microbiota in Minors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057268

Enrollment

Registered

2025-03-12

Start date

2018-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

DHA and EPA-enriched milk beverage

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The age at consent is 9-15years old 2) Be attending school at consent

Exclusion criteria

Exclusion criteria: 1) Having allergy to milk 2) Use a antipsychotics drug 3) Use ethyl icosapentate (e.g., Epadel) or ethyl omega-3 fatty acid (Lotriga) 4) Taking supplements that is expected to improve brain function 5) Having a habit of ingesting fats and oils as they are.

Design outcomes

Primary

Measure	Time frame
The effects of DHA and EPA -enriched milk beverage ingestion on emotion	—

Secondary

Measure	Time frame
1) The effects of DHA and EPA -enriched milk beverage ingestion on intestinal microbiome 2) The effects of DHA and EPA -enriched milk beverage ingestion on omega-3 Index	—

Countries

Japan

Contacts

Public ContactTakashi Ichinose

FUJI OIL CO., LTD. Research Institute for Creating the future

ichinose.takashi@so.fujioil.co.jp0297-52-6325

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026